NDC 67184-0513

Irinotecan Hydrochloride

Irinotecan Hydrochloride

Irinotecan Hydrochloride is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Qilu Pharmaceutical Co., Ltd.. The primary component is Irinotecan Hydrochloride.

Product ID67184-0513_09f0bae8-1859-4276-ae37-0f7a2200ac99
NDC67184-0513
Product TypeHuman Prescription Drug
Proprietary NameIrinotecan Hydrochloride
Generic NameIrinotecan Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2016-05-03
Marketing CategoryANDA / ANDA
Application NumberANDA203380
Labeler NameQilu Pharmaceutical Co., Ltd.
Substance NameIRINOTECAN HYDROCHLORIDE
Active Ingredient Strength20 mg/mL
Pharm ClassesTopoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 67184-0513-1

1 VIAL, SINGLE-USE in 1 CARTON (67184-0513-1) > 15 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2016-05-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67184-0513-1 [67184051301]

Irinotecan Hydrochloride INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA203380
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-05-03

Drug Details

Active Ingredients

IngredientStrength
IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacological Class

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]
  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

NDC Crossover Matching brand name "Irinotecan Hydrochloride" or generic name "Irinotecan Hydrochloride"

NDCBrand NameGeneric Name
0143-9583Irinotecan HydrochlorideIrinotecan Hydrochloride
0143-9701Irinotecan HydrochlorideIrinotecan Hydrochloride
0143-9702Irinotecan HydrochlorideIrinotecan Hydrochloride
0703-4432Irinotecan HydrochlorideIrinotecan Hydrochloride
0703-4434Irinotecan HydrochlorideIrinotecan Hydrochloride
16714-027Irinotecan hydrochlorideIrinotecan hydrochloride
16714-131Irinotecan hydrochlorideIrinotecan hydrochloride
16714-725Irinotecan HydrochlorideIrinotecan Hydrochloride
16714-726Irinotecan HydrochlorideIrinotecan Hydrochloride
23155-179Irinotecan HydrochlorideIrinotecan Hydrochloride
25021-230Irinotecan Hydrochlorideirinotecan hydrochloride
45963-614Irinotecan hydrochlorideIrinotecan hydrochloride
50742-401Irinotecan HydrochlorideIrinotecan Hydrochloride
68001-284Irinotecan HydrochlorideIrinotecan Hydrochloride
50742-402Irinotecan HydrochlorideIrinotecan Hydrochloride
59923-714Irinotecan HydrochlorideIrinotecan Hydrochloride
59923-702Irinotecan HydrochlorideIrinotecan Hydrochloride
60505-6128Irinotecan HydrochlorideIrinotecan Hydrochloride
59923-715Irinotecan HydrochlorideIrinotecan Hydrochloride
61703-349Irinotecan HydrochlorideIrinotecan Hydrochloride
63323-193Irinotecan HydrochlorideIrinotecan Hydrochloride
67184-0513Irinotecan HydrochlorideIrinotecan Hydrochloride
67184-0512Irinotecan HydrochlorideIrinotecan Hydrochloride
67184-0511Irinotecan HydrochlorideIrinotecan Hydrochloride
68083-382Irinotecan hydrochlorideIrinotecan hydrochloride
59923-716Irinotecan HydrochlorideIrinotecan Hydrochloride
0009-1111Camptosaririnotecan hydrochloride
0009-7529Camptosaririnotecan hydrochloride
15054-0043OnivydeIRINOTECAN HYDROCHLORIDE
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.